Fiche centre
CHU de Toulouse - Hôpital des Enfants
Toulouse — France
Essais liés2clinical trials
VilleToulouselocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT02636686
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Obinutuzumab | Lupus | Phase 2 | NCT05039619 | POSTERITY — A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants | RECRUITING |
| Drisapersen | Myopathies | À vérifier | NCT02636686 | Extension Study of Drisapersen in DMD Subjects | NO_LONGER_AVAILABLE |